Sachin Katyal received his B.Sc. (Biochemistry) from the University of Alberta and received his Ph.D. (Oncology) at the Cross Cancer Institute and the University of Alberta. His post-doctoral training, at St. Jude Children’s Research Hospital, in the area of DNA damage and repair in neurodevelopment and neuro-oncology was done in the lab of Dr. Peter McKinnon; work that led to publications in internationally-renowned journals such as Nature, Nature Neuroscienceand EMBO J. In 2013, Dr. Katyal began his independent academic research position at the University of Manitoba and CancerCare Manitoba where he is an Assistant Professor within the Department of Pharmacology and Therapeutics (D-PT) and, a Senior Scientist within the Research Institute of Oncology and Hematology (RIOH). Dr. Katyal’s research is CIHR- and TFRI-funded; he is the recipient of the CIHR Institute of Cancer Research 2014 Early Career Award in Cancer Research, a CIHR New Investigator award and a TFRI New Investigator Award. He serves on several scientific review committees for international academic journals and grant review panels. More recently, Sachin established industrial partnerships, which have facilitated the development of innovative technology and methodology to accelerate his DNA damage repair research program. These were instrumental for his recently-funded CFI JELF award to develop a novel high-throughput genotoxicity and drug screening facility to understand and identify new therapies against brain tumours and leukemia. Sachin is also actively involved in trainee development, mentorship and career progression through various University-wide initiatives, courses and workshops.